Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

Hysterectomy 2 remimazolam 1 relugolix 1 Uterine Myomectomy 1 Tranylcypromine 1 Tranexamic Acid 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Observation 1 Misoprostol 1 Hysteroscopy 1 CA-125 Antigen 1 Buthionine Sulfoximine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Myofibroma × remimazolam × Clear all

NCT05025410 2022-04-25

Remimazolam and Remifentanil Without Neuromuscular Blocking Agent

Seoul National University Bundang Hospital

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡